Concepedia

Paul W. Finn

PW

Statistics

Publications

38

Citations

2.5K

H-Index

21

Active since

1984

Affiliations

Oxford Drug Design (United Kingdom)(Current)

Pfizer (United Kingdom)

University of Oxford

Latvijas Organiskās Sintēzes Institūts

Rice University

Paul W. Finn is an author at Oxford Drug Design (United Kingdom) specializing in drug discovery, medicinal chemistry, and pharmacy.

Publications per year

1984–2019

38

Publications

38

Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors

Nagma Khan, Michael Jeffers, Sampath Kumar et al. · Biochemical Journal · 2007 · 710 citations · Full text

, , +10

Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101.

Jane A. Plumb, Paul W. Finn, Robert J. Williams et al. · PubMed · 2003 · 313 citations

, , +15

Quantitative Proteomic Analysis of Post-translational Modifications of Human Histones

Hans Christian Beck, Eva C. Nielsen, Rune Matthiesen et al. · Molecular & Cellular Proteomics · 2006 · 197 citations · Full text

, , +17

Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo

Nicola Steele, Paul W. Finn, Robert Brown et al. · British Journal of Cancer · 2009 · 146 citations · Full text

, , +17

Pharmacophore Discovery Using the Inductive Logic Programming System PROGOL

Paul W. Finn, Stephen Muggleton, David Page et al. · Machine Learning · 1998 · 139 citations · Full text

, , +12

1–5 of 38